In the News: Prince’s Pain

May 9, 2016 by C. Scott McMillin

It may turn out that chronic pain, like addiction, is one of those conditions that responds best to an approach that’s both individualized and ongoing, and requires considerable commitment on the patient’s part.

Topics: , ,


Heroin Commercial

April 25, 2016 by C. Scott McMillin

Heroin was a product of the Bayer Company of Germany, marketed as a preferred alternative to morphine– stronger, and thought to be safer

Topics: , ,


Drug Prices: ‘Invisible Hands’ Off

April 14, 2016 by C. Scott McMillin

A street dealer explained it: “That’s the dope business, man. You got to protect your corner.”

Topics:


Open the Buprenorphine Tap?

March 31, 2016 by C. Scott McMillin

Many physicians don’t want to offer opioid maintenance. They’re happy to refer out, to an addictionologist or psychiatrist with training.

Topics: , , , ,


The Public Trust

March 28, 2016 by C. Scott McMillin

The public needs to trust the people and institutions that provide the care they depend on when they (or someone they love) is sick.

Topics:


New CDC Guidelines for Opioid Prescription

March 21, 2016 by C. Scott McMillin

I always encourage family members with concerns about a loved one’s opioid use to communicate directly with the prescriber.

Topics: ,


Horror Story

March 17, 2016 by C. Scott McMillin

In a way, drug trial catastrophes are like airline disasters, in that the aura of secrecy extends well beyond the incident itself.

Topics: , ,


The OD Epidemic Continues…

January 28, 2016 by C. Scott McMillin

Prescription ODs now account for more fatalities than automobile accidents.

Topics: , ,


And the Winner Is…

December 28, 2015 by C. Scott McMillin

A piece of business worth $9 billion a year is precious to Big Pharma.

Topics: ,


In the News: A Roundup

December 14, 2015 by C. Scott McMillin

It’s simply evidence of the shift by chronic users to a cheaper, more readily available alternative.

Topics: , , ,


Subscribe to RecoverySI via Email


New Content